Despite a few limitations such as lack of overall survival and follow-up data, our results justify the importance of EpCAM separately and the connection between overexpression of two CSCs markers (EpCAM, CD166) and tumor aggressiveness in CRC tissues. Here, EPCAM is linked to neoplasm.